ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 698095 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 698095; 2) Community: the network communities that were significantly associated with the response to NSC 698095; 3) Molecule: the relationships between components within communities and NSC 698095; 4) MDR: the compounds that were significantly associated with the NSC 698095.

NSC Compound Enrichment Correlation
NSC 306107 2-Naphthalenecarboxylic acid, 4,4'-methylenebis[3-hydroxy-, bis[tris(4-aminophenyl)methyl] ester 0.0195202843390061 0.096825286
NSC 3091 Ammonium, [.alpha.-[p-(dimethylamino)phenyl]-.alpha.-[4-(dimethyliminio)-2,5-cyclohexadien-1-ylidene]-p-tolyl]ethyldimethyl-, bromide, chloride (8CI) 0.0195202843390061 0.095811369
NSC 328186 3',4',5'-trimethoxy-3-hydroxy flavone 0.0195202843390061 0.30840897
NSC 637459 Macrocalyxoformin B (Rabdosia diterpenoids) 0.0195202843390061 -0.010187651
NSC 668600 Null 0.0195202843390061 0.15387528
NSC 680420 Null 0.0195202843390061 0.3781291
NSC 681634 Camptothecin Derivative 0.0195202843390061 0.38334229
NSC 681644 Camptothecin Derivative 0.0195202843390061 0.39590771
NSC 689137 Null 0.0195202843390061 0.36335051
NSC 690042 6H-Pyrido[2,3,4-kl]acridin-6-one, 4-methoxy- 0.0195202843390061 0.12729239
Total:70  Current:26    [First] [Prev] [Next] [Last]